Uploaded July 2022 | Updated September 2026, 2 weeks ago
Vaccinated Vs. Unvaccinated Qatari Cohort (New Studies)
As promised, here is the lecture for the comparison of protection offered by vaccine vs., natural infection in Qatar's population. Let's review.
If you like this content and want more, I am doing a special one-time membership offer. Click here: drbeen.com/yt-special-p
Want to support this work?:
Buy me a coffee :-) buymeacoffee.com/DrMobeenSyed
Become my patron: patreon.com/mobeensyed?fan_landing=true
PayPal: paypal.me/mobeensyed?locale.x=en_US
My substack: mobeensyedmd.substack.com
Mobeen on locals: mobeen.locals.com
#drbeen #koolbeens #COVID
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
URL list from Friday, Jul. 15 2022
Duration of immune protection of SARS-CoV-2 natural infection against reinfection in Qatar | medRxiv
medrxiv.org/content/10.1101/2022.07.06.22277306v1
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar | Nature Communications
nature.com/articles/s41467-022-30895-3
One coronavirus infection wards off another — but only if it’s a similar variant
nature.com/articles/d41586-022-01914-6
SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis | BMC Infectious Diseases | Full Text
bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-022-07418-y
Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease
medrxiv.org/content/10.1101/2022.04.12.22273745v1.full.pdf
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM
nejm.org/doi/full/10.1056/nejmoa2114114
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM
nejm.org/doi/full/10.1056/NEJMc2117933
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections
nejm.org/doi/pdf/10.1056/NEJMoa2203965
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar | NEJM
nejm.org/doi/full/10.1056/NEJMoa2200797
Outcomes of SARS-CoV-2 Reinfection | Research Square
researchsquare.com/article/rs-1749502/v1
Long COVID risk falls only slightly after vaccination, huge study shows
nature.com/articles/d41586-022-01453-0
Vaccinated Vs. Unvaccinated Qatari Cohort (New Studies)
As promised, here is the lecture for the comparison of protection offered by vaccine vs., natural infection in Qatar's population. Let's review.
If you like this content and want more, I am doing a special one-time membership offer. Click here: drbeen.com/yt-special-p
Want to support this work?:
Buy me a coffee :-) buymeacoffee.com/DrMobeenSyed
Become my patron: patreon.com/mobeensyed?fan_landing=true
PayPal: paypal.me/mobeensyed?locale.x=en_US
My substack: mobeensyedmd.substack.com
Mobeen on locals: mobeen.locals.com
#drbeen #koolbeens #COVID
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
URL list from Friday, Jul. 15 2022
Duration of immune protection of SARS-CoV-2 natural infection against reinfection in Qatar | medRxiv
medrxiv.org/content/10.1101/2022.07.06.22277306v1
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar | Nature Communications
nature.com/articles/s41467-022-30895-3
One coronavirus infection wards off another — but only if it’s a similar variant
nature.com/articles/d41586-022-01914-6
SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis | BMC Infectious Diseases | Full Text
bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-022-07418-y
Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease
medrxiv.org/content/10.1101/2022.04.12.22273745v1.full.pdf
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM
nejm.org/doi/full/10.1056/nejmoa2114114
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM
nejm.org/doi/full/10.1056/NEJMc2117933
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections
nejm.org/doi/pdf/10.1056/NEJMoa2203965
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar | NEJM
nejm.org/doi/full/10.1056/NEJMoa2200797
Outcomes of SARS-CoV-2 Reinfection | Research Square
researchsquare.com/article/rs-1749502/v1
Long COVID risk falls only slightly after vaccination, huge study shows
nature.com/articles/d41586-022-01453-0
